Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating bempedoic acid versus statins in primary-prevention patients with suboptimal statin adherence, focusing on LDL-C reduction and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bempedoic Acid (bempedoic acid)
  • Statin (unspecified)

Snippet

Sponsor: Sohaib Ashraf | Conditions: Cardiovascular | Phase 3 | Status: NOT_YET_RECRUITING